Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesHyperactivated B cells in human inflammatory bowel disease
Journal of Leukocyte Biology, 10/06/09
Noronha AM et al. – TLR2+ B cells are associated with clinical measures of disease activity and differentially associated with CD– and UC–specific patterns of inflammatory mediators, suggesting a formerly unappreciated role of B cells in the pathogenesis of IBD.
Related Articles
IBD drugs and cancer risk
JAMA, 11/18/09
Relevance Score: 87%
Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD
Gastroenterology Clinics of North America, 11/13/09
Relevance Score: 87%
Diagnostic Role and Clinical Association of ASCA and ANCA in Brazilian Patients with Inflammatory Bowel Disease
Digestive Diseases and Sciences, 10/19/09
Relevance Score: 87%
Safety Profile of IBD Therapeutics: Infectious Risks
Gastroenterology Clinics of North America, 11/19/09
Relevance Score: 85%
Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09
Relevance Score: 85%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of appendicectomy in the subsequent development of inflammatory bowel disease: a UK-based study
International Journal of Colorectal Disease, 12/18/09
Delayed Colonic Perforation after ESD in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature
The Internet Journal of Gastroenterology, 12/18/09
Clinical outcome of newly diagnosed Crohns disease: a comparative, retrospective study before and after infliximab availability
Alimentary Pharmacology and Therapeutics, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor